ESSA Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPIX research report →
About the company
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials.
- CEO
- David Ross Parkinson
- IPO
- 2015
- Employees
- 35
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $9.52M
- P/E
- -0.48
- P/S
- 0.00
- P/B
- 0.08
- EV/EBITDA
- 3.85
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -16.63%
- ROIC
- -20.26%
- Revenue
- $0 · 0.00%
- Net Income
- $-28,542,821 · -7.38%
- EPS
- $-0.64 · -6.67%
- Op Income
- $-34,421,017
- FCF YoY
- -14.83%
- 52W High
- $6.45
- 52W Low
- $0.18
- 50D MA
- $0.83
- 200D MA
- $1.49
- Beta
- 1.53
- Avg Volume
- 6.75M
Get TickerSpark's AI analysis on EPIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 9, 25 | Parkinson David Ross | sell | 65,675 |
| Oct 9, 25 | Wood David S. | sell | 33,343 |
| Oct 9, 25 | BERGER FRANKLIN M | sell | 784,404 |
| Oct 9, 25 | Glickman Richard M | sell | 43,240 |
| Oct 9, 25 | Requadt Scott | sell | 30,002 |
| Oct 9, 25 | Martin John Alexander | sell | 14,299 |
| Oct 9, 25 | Thorell Marella | sell | 2,881 |
| Oct 9, 25 | BVF PARTNERS L P/IL | other | 560,797 |
| Aug 5, 25 | BVF PARTNERS L P/IL | other | 1,481,634 |
| Aug 5, 25 | BVF PARTNERS L P/IL | sell | 79 |
Our EPIX coverage
Recent articles, reports, and earnings notes.
No research on EPIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EPIX report →Similar companies
Peers in the same neighborhood.